Looking for an expert overview of highlights from #EASLCongress#?
In this short video, Dr Silvia Vilarinho and Dr Deepak Joshi discuss key takeaways in late-onset genetic cholestasis and Alagille syndrome.
Start watching now:
Prof. Carola Dröge and Prof. Verena Keitel-Anselmino speak live from #EASLCongress#, discussing IBAT inhibitor therapy in adults with hereditary BSEP-deficiency.
Watch the full video:
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which unmet need in HF with kidney impairment management are you most hopeful new evidence will address?
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
A patient's eGFR dips after starting an SGLT2 inhibitor. What's your first move?
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
What's the biggest barrier to optimising HF GDMT in patients with kidney impairment?
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which kidney biomarker most influences your heart failure management decisions?
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
How often do you test UACR (urine albumin-to-creatinine ratio) in patients with HF?